KeyBanc analyst Paul Knight reiterated an Overweight rating and $14.00 price target on Avid Bioservices (NASDAQ: CDMO).The analyst commented, "CDMO ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE